By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
News for IndiaNews for IndiaNews for India
  • Home
  • Posts
  • Search Page
  • About us
Reading: Stocks making the biggest moves midday: Nvidia, Ollie’s Bargain Outlet, Birkenstock, Disney and more
Share
Font ResizerAa
News for IndiaNews for India
Font ResizerAa
  • Economics
  • Business
  • Home
  • Categories
    • Business
    • Economics
  • About us
  • Sitemap
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
News for India > Finance > Stocks making the biggest moves midday: Nvidia, Ollie’s Bargain Outlet, Birkenstock, Disney and more
Finance

Stocks making the biggest moves midday: Nvidia, Ollie’s Bargain Outlet, Birkenstock, Disney and more

Last updated: December 18, 2024 10:36 pm
5 months ago
Share
SHARE


Check out the companies making headlines in midday trading. Nvidia – Nvidia shares popped more than 4%, reversing earlier week-to-date losses that pushed the stock briefly into correction territory. Shares have surged more than 175% since the start of 2024. General Mills — The consumer products maker slid 2.6% after telling investors to expect a weaker outlook than previously expected. General Mills said adjusted earnings per share should pull back by between 3% and 1%, despite an earlier range of between a loss of 1% and gain of 1%. Jabil — The electronics components stock surged 9.5% after earnings and guidance surpassed Wall Street expectations. Jabil posted $2 in core earnings per share on $6.99 billion in revenue for the first quarter, while analysts surveyed by FactSet anticipated just $1.88 a share and $6.61 billion. Heico — The aerospace stock tumbled 10% on weaker-than-expected revenue. Heico reported $1.01 billion, just shy of the $1.03 billion consensus forecast from analysts, according to FactSet. Ollie’s Bargain Outlet — The retail stock added 2.4% and hit a 52-week high following a double upgrade at Citi to buy from sell. The bank called Ollie’s the “king of closeouts” and believes the company is well-positioned to win in the uncertain retail landscape. Xometry – Shares gained more than 7% after JPMorgan upgraded the artificial intelligence-powered industrial marketplace to overweight from neutral . The investment bank said it’s one of the “best secular growth stories across our coverage universe” for the next three to five years. Netgear – Shares jumped 11.8% after the Wall Street Journal reported that the U.S. is considering a ban on routers made in China. Netgear, which is based in California, can benefit given it also produces routers. Birkenstock — The shoe maker jumped 4.5% on the back of better-than-anticipated earnings and revenue for the fourth fiscal quarter. Adjusted earnings before interest, taxes, depreciation and amortization also exceeded expectations. Rivian — The electric vehicle stock shed 4% following a downgrade to neutral from outperform at Baird. While the firm remains positive on Rivian’s long-term prospects, there’s “sees few catalysts in 2025” and “sluggish” EV sales ahead. Box — The content solutions stock climbed 1.9% on the heels of an initiation at buy from DA Davidson. The firm said the company is in the early innings of a “positive inflection to growth” following recent platform expansions. Disney — The entertainment giant saw shares jumping about 2% after Morgan Stanley named the stock a top pick in 2025. The Wall Street firm said it expects “substantial” streaming profits from both Disney and Warner Bros Discovery. Academy Sports — The sporting goods retailer popped 3.9% following Citi’s initiation at a buy rating. Citi said the company has a noteworthy growth runway. Expedia — The online travel booking platform rose 2% after Bank of America’s upgrade to buy from neutral. The bank dubbed Expedia a top value stock tied to the internet. DoubleVerify — The software stock added 3% following an initiation at outperform from Raymond James. The firm called DoubleVerify a market leader. Rocket Pharmaceuticals — The biotech stock advanced 5% after Jefferies initiated coverage of Rocket Pharmaceuticals with a buy rating, saying the company has a promising pipeline of gene therapies for rare diseases. In particular, analyst Andrew Tsai expects a clinical trial for RP-A501 (AAV9) , a treatment for Danon disease, will be successful, and serve as a positive catalyst for the stock. — CNBC’s Samantha Subin, Yun Li, Lisa Han, Sean Conlon, Michelle Fox and Sarah Min contributed reporting



Source link

You Might Also Like

Credit default swaps are back in fashion — even if the panic might be overblown

Stocks making the biggest moves after hours: Nvidia, Salesforce, HP and more

Palantir teams up with Fannie Mae in AI push to sniff out mortgage fraud

Fed worried it could face ‘difficult tradeoffs’ if tariffs reaggravate inflation, minutes show

Stocks making the biggest moves midday: Abercrombie & Fitch, Okta, Vail Resorts, GameStop and more

TAGGED:Academy Sports and Outdoors IncBirkenstock Holding PLCBox IncBreaking News: MarketsBusinessBusiness NewsCiti Trends IncDoubleVerify Holdings IncEarningsEconomyExpedia Group IncFactSet Research Systems IncGeneral Mills IncHEICO CorpJabil IncMarket InsiderMarketsNETGEAR IncNVIDIA CorpOllie's Bargain Outlet Holdings Incregwall-marketmoversRivian Automotive IncRocket Pharmaceuticals IncSean ConlonStock marketsWalt Disney CoXometry Inc
Share This Article
Facebook Twitter Email Print
Previous Article Mamata Machinery IPO raises ₹53.55 crore from anchor investors ahead of public issue | Stock Market News
Next Article Chinese self-driving trucking company pivots to generative AI for video games

We influence 20 million users and is the number one business and technology news network on the planet.

Find Us on Socials

News for IndiaNews for India
© Wealth Wave Designed by Preet Patel. All Rights Reserved.
  • BUSINESS